| Dr Martin R Curlik, MD | |
|
1400 E Kincaid St, Mount Vernon, WA 98274-4127 | |
| (360) 814-6565 | |
| Not Available |
| Full Name | Dr Martin R Curlik |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 44 Years |
| Location | 1400 E Kincaid St, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255376166 | NPI | - | NPPES |
| 1565030 | Other | NJ | AMERIHEALTH PPO |
| 8219546 | Other | NJ | GHI |
| 0104669000 | Other | NJ | AMERIHEALTH HMO |
| 1121207 | Other | NJ | AETNA HMO |
| 4109260 | Other | NJ | AETNA |
| 061756559 | Other | NJ | BCBS OF NJ |
| P1082680 | Other | NJ | OXFORD |
| 1704605 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MA43259 (New Jersey) | Secondary |
| 208800000X | Urology | MD61294285 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Skagit Valley Hospital | Mount vernon, WA | Hospital |
| Island Hospital | Anacortes, WA | Hospital |
| Cascade Valley Hospital | Arlington, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Public Hospital Dist No 1 Skagit | 6800793522 | 248 |
News Archive
TVM Capital Healthcare Partners, the region's first private equity firm dedicated exclusively to the healthcare sector, has signed an affiliation with Joslin Diabetes Center.
Stem cell researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
The Bush administration has no overall strategy to ensure patient privacy as it promotes expanded use of electronic health records among insurers, doctors, hospitals and other health care providers, according to a recent Government Accountability Office report, the New York Times reports.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
› Verified 5 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
TVM Capital Healthcare Partners, the region's first private equity firm dedicated exclusively to the healthcare sector, has signed an affiliation with Joslin Diabetes Center.
Stem cell researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
The Bush administration has no overall strategy to ensure patient privacy as it promotes expanded use of electronic health records among insurers, doctors, hospitals and other health care providers, according to a recent Government Accountability Office report, the New York Times reports.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin R Curlik, MD 50 Union St, Suite 1400, Ellsworth, ME 04605-1534 Ph: (207) 664-5455 | Dr Martin R Curlik, MD 1400 E Kincaid St, Mount Vernon, WA 98274-4127 Ph: (360) 814-6565 |
News Archive
TVM Capital Healthcare Partners, the region's first private equity firm dedicated exclusively to the healthcare sector, has signed an affiliation with Joslin Diabetes Center.
Stem cell researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.
Scientists from the Broad Institute of Harvard and MIT, Lund University and Novartis have announced the discovery of three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.
The Bush administration has no overall strategy to ensure patient privacy as it promotes expanded use of electronic health records among insurers, doctors, hospitals and other health care providers, according to a recent Government Accountability Office report, the New York Times reports.
The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
› Verified 5 days ago
Jordan James Kramer, MD Urology Medicare: Medicare Enrolled Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 Fax: 360-814-6380 | |
Dr. Laurence M. Lee, MD Urology Medicare: Medicare Enrolled Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 | |
Dr. Winston G. Jones, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 | |
Dr. Richard Von Ho, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 Fax: 360-814-6380 | |
Dr. Curran James Emeruwa, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-6565 | |
Dr. Darrell R. Cornelius, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1311 E. Division Street, Mount Vernon, WA 98274 Phone: 360-424-7991 Fax: 360-428-4377 |